Boehringer Ingelheim and Eli Lilly are seeking regulatory approval for an experimental drug to treat Type 2 diabetes, the companies said.
The Food and Drug Administration has granted priority review to an experimental drug made by ViiV Healthcare for HIV, the company, a joint venture between British drug maker GlaxoSmithKline and American drug maker Pfizer, announced.
The Food and Drug Administration has granted special designation to a drug made by Eisai for treating thyroid cancer.
A panel of Food and Drug Administration experts has recommended approval for an experimental drug made by Boehringer Ingelheim for chronic obstructive pulmonary disease, the drug maker said.
An experimental drug for Lou Gehrig's disease made by Biogen Idec has failed in a late-stage clinical trial, the drug maker said.
The Food and Drug Administration has accepted a regulatory approval application from Takeda and Lundbeck for an experimental drug to treat depression, the companies said Wednesday.
A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.
The Food and Drug Administration has accepted an application from Merck for an experimental drug for insomnia, the drug maker said Thursday.
A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.
An experimental drug made by Pfizer for a rare and fatal neurodegenerative disease got a favorable vote from a Food and Drug Administration expert panel.
Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.
An online plea for help from a mother dying of breast cancer prompted the manufacturer of an experimental drug to release it early, according to published reports.
The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.
Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.
An advisory committee of the Food and Drug Administration unanimously recommended approval for an investigational...